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Past studies have shown that successful development and commercialisation of modern biotechnology 
products depends heavily on public acceptance. Of the many variables studied by earlier researchers, it 
was found that moral acceptability was an important predictor of support for biotechnology. The 
purpose of this paper is to examine the ethical perception of modern biotechnology among the public in 
the Klang Valley region of Malaysia and to compare their ethical perception across several 
demographic variables. A survey was carried out using a self-constructed multi-dimensional instrument 
measuring the ethical perception of modern biotechnology. The respondents (n = 434) were stratified 
according to stakeholder groups which consisted of eleven groups: Producers, scientists, policy 
makers, NGOs, the media, religious scholars, university students and consumers. Results from the 
survey showed that the Klang Valley public did not perceive modern biotechnology as very threatening 
to the natural order of things (mean score 3.76) and they recognised the high benefits that modern 
biotechnology could provide to society (mean score 5.31). However, they also stressed that humans do 
not have the absolute right to modify living things (mean score 3.55) and they perceived modern 
biotechnology as moderately risky (mean score 4.59), whilst they had moderate confidence in 
regulation (mean score 4.09) and stressed the high need for proper labelling of modern biotechnology 
products (mean score 5.70). Background variables such as religion, race, age, education level and 
gender have significant effect on some of the dimensions of Malaysians’ ethical perception of modern 
biotechnology. The research findings are useful for understanding the social construct of the ethical 
acceptance of modern biotechnology in a developing country. 
 





Malaysia aims to use biotechnology as an economic 
growth vehicle by the year 2020 (Firdaus-Raih et al., 
2005; BIOTEK, 2010). Being an agriculture-based nation, 
the strength of biotechnology in Malaysia is in agricultural 
biotechnology which is foreseen as a potential tool to 
ensure food security and to boost the country's economy 
(Latifah et al., 2007). Successful development and 
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Abbreviations: GMOs, Genetically modified organisms; GM, 
genetically modified. 
Malaysia depends greatly on the acceptance by the 
Malaysian public. In order to reap the potential economic 
and social benefits of modern biotechnology, consumer 
acceptance issues have to be addressed (Stenholm and 
Waggoner, 1992). In addition, Sjoberg (2008) empha-
sizes that the reactions and attitudes of the public to gene 
technology constitute important areas of research due to 
their relation to acceptance or rejection of policies. Since, 
modern biotechnology is new and the advancement in 
these areas has been so rapid, it has been the object of 
some doubts, fears and concerns, as well as an intense 
and divisive debate worldwide on the potential risks to 
human health, to the environment and to society (Costa-
Font and Gil, 2009). The debate was typically seen as a 
conflict between supporters  who  envisage  the  potential 
 
 




benefits and the opposition groups who view genetically 
modified (GM) products as tampering with nature 
(Bloomfield, 2011). 
According to Batalion (2000), the central problem 
underlying the use of biotechnology is not just its short-
term benefits and long-term drawbacks, but the overall 
attempt to “control” living nature on an erroneous 
mechanistic view. Humans generally have a conscience 
and religious beliefs and many of these religious beliefs 
do not allow unrestricted interference with life, such that 
happens in genetic engineering (Epstein, 1998). The 
pace of discovery in genetic-based biotechnology is very 
rapid and there is anxiety that a kind of technological 
compulsion (‘if we can do it, let’s do it’) has been driving 
developments ahead of proper ethical consideration of 
their propriety (Polkinghorne, 2000). 
Furedi (1997) argues that societal and individual risk 
perceptions are proportional to a system of moral values. 
Individuals were willing to accept some level of risk if a 
product was deemed worthy and was not morally 
objectionable. Of the variables studied, namely, useful-
ness, perceived risk and morality, it was found that moral 
acceptability was the strongest predictor of support for 
biotechnology by Canadians (Eisendel, 2000). Gaskell et 
al. (2000) also noticed that moral acceptability appeared 
to act as a veto for the support of biotechnology among 
Europeans. The results of the US public survey (Priest, 
2000) also suggested the possibility of the US population 
using moral reasoning in forming opinions towards six 
applications of biotechnology. 
Basic categories of moral or ethical concerns regarding 
modern biotechnology fall into two classes: Intrinsic and 
extrinsic (Comstock, 2000). Extrinsic objection refers to 
the concerns regarding the possible risks of different 
applications of biotechnology to human health, the 
environment, the economy and society (Gott and 
Monamy, 2004). The societal concerns include the need 
for labelling (Wansink and Kim, 2001) and the patenting 
rights of multinational companies and scientists 
(Potrykus, 2001). The patenting of living things is 
objected to by many, on the grounds that genes are 
naturally occurring entities and the methods for transferring 
them to plants or animals are well-known and 
straightforward (EFB, 1996). On the other hand, the 
economic concerns include denying the benefits of 
modern biotechnology to society, the economy and 
farmers (BABAS, 2009) and the monopoly of the modern 
biotechnology products market by giant companies 
(Leisinger, 2007). 
Intrinsic objection alleges that the process of modern 
biotechnology is objectionable in itself.  This belief is 
associated with the claim that the technology is not natural, 
with the technology changing Nature and playing “God”. 
Other researchers have highlighted other intrinsic issues 
such as modern biotechnology being seen as threatening 
the natural order of living things (BABAS, 1999) and 





their own benefit. In some cases, the intrinsic concerns 
include a religious dimension when they are accom-
panied by an underlying set of religious beliefs and 
principles concerning the relationships between God, 
Nature and human beings (BABAS, 1999). Many reli-
gions do not allow unrestricted interference with life, such 
as genetic engineering (Epstein, 1998). 
Socio-demographic variables such as age, gender and 
education have been shown to affect people’s risk 
perception and attitude towards science (Connor and 
Siegrist, 2010; Simon, 2010). In general, men were less 
concerned about gene technology compared to women, 
and the level of education has an impact on attitude to 
modern biotechnology (Hallman et al., 2003). According 
to Kelley (1995), demographic characteristics such as 
age must be included because some researchers have 
argued that the continuing process of scientific discovery 
leaves older people behind and perceived risk tends to 
increase with age, up to a point, and then decreases, 
possibly due to health concerns or ageing (Grobe et al., 
1999). Since, the study is carried out in a multiracial 
country like Malaysia, it is also important to see whether 
there is any effect of race on ethical perceptions of 
biotechnology. 
The objective of this paper is to assess the ethical 
perception of modern biotechnology among the Malay-
sian public in the Klang Valley region and to compare 




MATERIALS AND METHODS 
 
Data for this study was collected by means of a survey using 
questionnaires carried out from early August 2009 to early February 
2010. The multi-dimensional instrument to measure ethical aspects 
of modern biotechnology used in this study was constructed based 
on the work of earlier research (Comstock, 2000; Gaskel et al., 
2003; BABAS, 1999; Glenn, 2004; Singh et al., 2006; Gott and 
Monamy, 2004). All items were measured on seven point Likert 
scales. The questionnaires were administered face-to-face with 434 
adult respondents (aged 18 years old and above) in the Klang 
Valley region. Since the respective populations for the stakeholders 
involved were mostly unknown, the respondents were chosen using 
a stratified purposive sampling technique, as recommended by 
Monroe and Monroe (1993). Although the samples chosen using 
this technique may not reflect the true population of Malaysia, this 
technique enabled the inclusion of respondents from different 
stakeholders’ groups that might otherwise be underrepresented if 
random sampling was used.  
Public acceptance of a new technology can be measured either 
by conducting a representative survey among lay people of a 
certain country, or it can focus on stakeholders’ representatives 
who contribute to the formation of public opinion and claim to 
represent certain public and private interests and concerns (Aerni, 
1999). Most of the earlier research concentrated on the 
representative public samples (Gaskell et al., 2003; Hallman, 2004; 
Hamstra, 1998), while other researchers such as Aerni (1999, 
2002) recommended the use of the stakeholder-based approach 
when it is difficult to run representative surveys in developing 
countries with a low level of public awareness towards  biotechnolo- 
 
 








Officers who have a company or organisation related to food, agriculture and 
pharmaceuticals. Company or organisation directly involved in the production of 
products of modern biotechnology, or has an interest to enter the field of modern 
biotechnology in the future. 
Scientists 




Individuals from organisations in which decisions and opinions would affect 
policy/national policies, laws and acts related to biotechnology as well as the 
country's biotechnology programs, including production, research, and trade. 
Group of non-governmental 
organisations (NGOs) 




Media group consisting of editors and news reporters from local newspapers, 
especially in science and technology (including areas of environment and research 
and development). 
University students University students with a science background, especially biology. 
Muslim scholars Officials of the Islamic organisations. 
Buddhist scholars Officials of the Buddhist organisations. 
Christian scholars Officials of the Christian organisations. 
Hindu scholars Officials of the Hindu organisations. 




gy. Since Malaysia is a developing country where the awareness 
level is not expected to be high, the stakeholder-based survey 
approach recommended by Aerni (1999, 2002) was adopted but a 
wider range of interest groups as well as consumers were included 
so that comparisons could be made. The respondents in this study 
were stratified according to stakeholders’ groups, which consisted 
of eleven groups: Producers, scientists, policy makers, NGOs, 
media, religious scholars, university students and consumers. The 
description of the selected groups is shown in Table 1. 
Taking into account that this study was quantitative, the minimum 
sample size required for each statistical analysis was considered. 
Comparison of attitudes across stakeholders (eleven groups) was 
to be carried out using analysis of variance (ANOVA). In order to 
have a medium effect size (f = 0.25) at P = 0.05, u = 10, a sample 
of 25 subjects per group is required to obtain a power of 0.80 
(Cohen 1969). So each stakeholder group, except for the general 
public, was allocated a minimum sample size of 25 but the number 
was increased where possible to take into account that some 
questionnaires might be incomplete or when the population size 
was bigger (Table 2).  38% of the respondents were male, 62% 
female, ages ranging from 17 to 64 years old, 13.6% of the 
respondents had at least a secondary level of education, 23.5% 
had pre-university education or were diploma holders while the 
remaining 62.9% had a tertiary level of education (degree and 
above). The majority of the stakeholders (except the consumers, 
religious scholars and university students) possessed at least a 
tertiary level of education, which resulted in a high percentage of 
respondents in this category but the number of respondents in the 
other categories met the minimum number required to carry out 
comparison using ANOVAs to achieve a medium effect size (n = 52 
at P = 0.05, to obtain a power of 0.80) as recommended by Cohen 
(1969). 
In a developing country like Malaysia, where biotechnology is still 
new, it is expected that the majority of the public may not know 
much about biotechnology. The conventional multiple indicator 
survey research approach, as proposed by Kelley (1995), was 
adopted in this study, which resulted in comprehensive items 
coverage. The public do not perceive technological risk according 
to a single dimension related to predicted injuries or fatalities akin to 
a risk assessor’s viewpoint but interpret risk as a multi-dimensional 
concept, concerned with broader qualitative attributes (Rowe, 
2004). Within this approach, multi-dimensional risk perception is 
invoked to explain the expert-lay disagreement that is ascribed to 
lay ignorance in the knowledge deficit model (Hansen et al., 2003). 
So the questionnaires were developed to be of the fixed response 
type to make it easier for the respondents to answer. The 
questionnaires were handed out personally to respondents by 
trained biotechnology graduate enumerators. Before answering, the 
respondents were given an introduction to basic concepts, 
examples and several possible benefits and risks related to several 
applications of modern biotechnology and they were also given the 
chance to enquire further. This approach was suggested by Kelley 
(1995) in order to assess unsophisticated public attitudes towards 
complex issues like modern biotechnology. This style works 
perfectly well for sophisticated respondents as well as unsophis-
ticated respondents, besides allowing the researchers to use 
sophisticated statistical multivariate procedures to discover whether 
the attitude responses are empirically sensible. By using a 
multiplicity of questions, measurement errors are reduced. 
Data analysis was carried out using SPSS version 14.0. A t-test 
was used to see the differences in the mean value across gender 
while the differences in mean values across age, educational level, 
religion, race and stakeholders groups were determined by 
ANOVAs. However, ANOVAs were only carried out across 
categories which had the minimum required number of respondents 
to achieve a medium effect size (f = 0.25) at P = 0.05, to obtain a 
power of 0.80 (Cohen, 1969). For race, the minimum required 
number of samples per category was 52 so comparisons were 
made only across the three major races: Malay, Chinese and 
Indian. As for religion, the minimum required number of samples 
per category was 44. This meant that comparisons were carried out 
only across the four major religions in Malaysia: Islam, Buddha, 
Hindu and Christian. For all other background variables, each 
category met the minimum number of required samples.  
 
 




Table 2. Background of respondents surveyed. 
 
Background Frequency Percentage 
Stakeholders’ group 
Producers 25 5.8 
Scientists 32 7.4 
Policy makers 39 9.0 
NGOs 26 6.0 
Media 29 6.7 
University students     44 10.1 
Islamic scholars 43 9.9 
Buddhist scholars 32 7.4 
Christian scholars 34 7.8 
Hindu scholars 34 7.8 
Consumers 96 22.1 
   
Gender 
Male 165 38.0 
Female 269 62.0 
   
Educational level   
Secondary 59 13.6 
Diploma/pre-U 102 23.5 
University 273 62.9 
   
Age 
18 - 25 years 201 46.3 
26 - 40 years 156 35.9 
≥ 41 years 77 17.7 
   
Race 
Malay 259 59.7 
Chinese 78 18.0 
Indian 72 16.6 
Sabah natives 11 2.5 
Sarawak natives 9 2.1 
Others 5 1.2 
   
Religion 
Islam 264 60.8 
Buddha 52 12.0 
Hindu 60 13.8 
Christian 52 12.0 






Ethical dimensions  
 
An exploratory principal component factor analysis follow- 
ed by varimax rotation was carried out to identify items 





with eigen values greater than one were extracted and 
were able to account for the majority of the variances in 
responses (66.68%), indicating that this as good instru-
ment that can measure the general ethical aspects of 
modern biotechnology. Table 3 shows the results of 
principal component factor analyses using varimax 
rotation. This rotation yielded meaningful item groupings 
or dimensions with strong, unambiguous loadings. All 
factor loading values were greater than 0.4, which can be 
considered as more significant, as suggested by Hair et 
al. (1992). 
The first factor or dimension was interpreted as market 
monopoly by giant companies and developed countries, 
where five items were strongly loaded on it. The second 
dimension with four items strongly loaded on it was 
labelled as risks to human health. The third dimension 
clearly reflected the labelling aspects of biotechnology, 
that is, the need for proper and appropriate labelling, and 
four items were strongly loaded on it as well. Five items 
were salient to the fourth factor which was labelled as 
modern biotechnology threatening the natural order of 
things. The fifth factor, which was made up of another 
five items represented perceived benefits. Another three 
items reflected the sixth dimension, described as public 
confidence in government regulation related to modern 
biotechnology. The items included whether the respon-
dents agreed that the regulations related to modern 
biotechnology and the regulatory action on experimental 
failure of GMOs is adequate in protecting the safety of 
Malaysian society and whether the government depart-
ment involved in modern biotechnology regulation has 
monitored the safety of modern biotechnology products 
efficiently. The last three items were most salient to the 
seventh dimension which related to whether humans 
possess the right to modify living things.  
 
 
Item analysis and reliability of the instrument 
 
To ensure that each item was measuring a similar 
dimension as the whole category itself, item scales were 
correlated with their total scales on all items of a 
category. As recommended by Aiken (1994) items that 
correlated with a magnitude of 0.30 or more with the 
category score were retained.  From Table 3, it can be 
seen that the corrected item-total correlations for almost 
all items in each dimension generally ranged from 
reasonably good (correlation value between 0.30 and 
0.39) to very good (correlation value greater than 0.40) 
(Matlock-Hetzel, 1997). It can be concluded that all the 
items in each dimension are strongly valid to measure 
ethical aspects of modern biotechnology. Cronbach’s 
coefficient was used to calculate the reliability of all 
dimensions. Table 2 shows, the standardised alpha 








Table 3. Factor loadings and Cronbach’s alpha values of general ethical aspects. 
 





Alpha if item 
deleted 
α 
The need for labelling    0.85 
Labelling is producer’s responsibility  0.82 0.62 0.84  
Labelling to differentiate GM and non-GM products 0.82 0.75 0.78  
Labelling to give information 0.76 0.78 0.77  
Labelling important for allergic people 0.71 0.62 0.84  
     
Risks to human health    0.84 
Babies may become premature  0.81 0.64 0.81  
Increase human fatality 0.77 0.59 0.83  
Give rise to unknown diseases 0.76 0.69 0.80  
Produce antibiotic resistant bacteria 0.65 0.66 0.81  
May cause the transfer of animal disease to human 0.60 0.66 0.81  
     
Threaten natural order  of things     0.77 
Modification considered over the limit 0.81 0.58 0.71  
Cross the natural boundaries between different species  0.80 0.70 0.67  
Interfere with the living organism natural integrity 0.79 0.66 0.68  
Modern biotechnology considered as blasphemy 0.66 0.42 0.77  
Reduce the economic value of living organism 0.48 0.36 0.79  
     
Human rights to modify  living things     
Human has the right to modify living thing  0.79 0.48 0.52 0.64 
If animal do not feel pain, human can modify their 
genetics makeup                                                                                                              
0.68 0.39 0.59  
The use of animals is appropriate 0.64 0.50 0.51  
Has the ability to cure inherited disease 0.50 0.32 0.63  
     
Monopoly    0.76 
 Product market dominated by giant companies 0.76 0.59 0.69  
May cause economy divide  0.75 0.63 0.68  
Bring increase in bioterrorism 0.73 0.53 0.71  
Developed countries monopoly the global market  0.70 0.61 0.69  
Equal status between non-living and living organisms 0.40 0.32 0.80  
     
Patenting rights    0.76 
Patent needed to protect  scientist IP rights 0.86 0.63 0.62  
Industry encouraged to patent their innovation 0.76 0.62 0.63  
IP to cover developmental cost by  industry 0.70 0.64 0.63  
Human status more superior than animal/plant 0.41 0.31 0.82  
     
Confidence on regulation    0.65 
Regulation adequate 0.77 0.49 0.50  
Efficient monitoring by Govt  dept  0.75 0.42 0.60  




Ethical perception of modern biotechnology 
 
Overall, the Klang Valley public perceived modern bio- 
technology as not very threatening to the natural order of 
things (mean score 3.76) and recognised the high bene-
fits that modern  biotechnology  could  provide  to  society  
 
 




Table 4.  Ethical perception of modern biotechnology. 
 
Dimension Mean score ± Standard deviation Interpretation 
Threatening the natural order of things 3.76  ± 1.14 Moderate 
Risks to human health 4.59  ± 1.11 Moderate 
Human rights to modify living things 3.55  ± 1.18 Moderate 
Monopoly by giant companies and developed countries 5.05  ± 1.02 High 
The need for proper and appropriate labelling 5.70  ± 1.20 High 
Perceived benefits 5.31  ± 1.17 High 
Confidence on government regulation towards GMO 4.09  ± 1.11 Moderate 
 




(mean score 5.31) (Table 4). However, they also stressed 
that humans do not have the absolute right to modify 
living things (mean score 3.55), whilst they perceived 
modern biotechnology as moderately risky (mean score 
4.59) and expressed a high degree of concern that the 
global market of modern biotechnology is being monopo-
lised by large companies and developed countries (mean 
score of 5.05). The respondents exhibited only moderate 
confidence in government regulation (mean score 4.09) 
and expressed a high level of need for the proper 




Perception across age groups 
 
Respondents from all age groups perceived modern 
biotechnology as not very threatening to the natural order 
of things (mean scores below the mid-point value of 4.0) 
and they perceived that modern biotechnology has high 
potential benefits to society (mean score above 5.0). 
However, they also expressed that humans do not have 
the absolute right to modify living things for their own 
benefit (mean scores below the mid-point value of 4.0), 
they rated modern biotechnology as moderately risky to 
human health (mean score above the mid-point value of 
4.0) and they perceived the technology as being highly 
monopolised by giant companies and developed 
countries (mean score above 5.0). They considered 
modern biotechnology as having a high need for proper 
and appropriate labelling (mean score above 5.0). With 
regard to regulation, the youth respondents (18 to 25 and 
26 to 40 years) were moderately confident in government 
regulation of GMOs (mean score above the mid-point 
value of 4.0) (Table 5) but the adults (41 years and 
above) thought otherwise (mean-score below the mid-
point value of 4). ANOVA showed significant differences 
in the ranking of humans having the right to modify living 
things and confidence in regulation by the respondents 
across ages (F = 8.36, p < 0.001). The post hoc test 
confirmed that the youth respondents (18 to 25 and 26 to 
40 years) felt that humans have more rights to modify 
living things and were more confident in government 
regulation of GMOs compared to the adults (41 years and 
above).  Grobe et al. (1999) also reported that perceived 
risk tended to increase with age. 
 
 
Ethical perception across educational levels 
 
Irrespective of educational level, all respondents per-
ceived modern biotechnology as not very threatening to 
the natural order of things (mean scores below the mid-
point value of 4.0) and that it has substantial potential 
benefits to society (mean score about 5.0 and above). 
However, they felt that humans do not have the absolute 
right to modify living things for their own benefit (mean 
scores below the mid-point value of 4.0), they ranked 
modern biotechnology as moderately risky to human 
health (mean score above the mid-point value of 4.0) and 
they considered modern biotechnology as having a high 
need for proper and appropriate labelling (mean score 
above 5.0). They also claimed to be moderately confident 
in government regulation of GMOs (mean score above 
the mid-point value of 4.0) (Table 6). ANOVA were 
significant for the factor monopoly by giant companies 
and developed countries (F = 5.88, p < 0.01), the need 
for proper and appropriate labelling (F = 6.17, p < 0.01), 
and perceived benefits (F = 9.61, p < 0.001). Further-
more, the post hoc tests confirmed that the respondents 
with a tertiary level of education rated modern 
biotechnology as having more potential benefits but at 
the same time believed that modern biotechnology needs 
more proper and appropriate labelling than those with 
lower levels of education. They also considered the 
monopoly level of modern biotechnology products by 
giant companies and developed countries as significantly 
lower than those with a diploma or pre-university level of 
education. Tucker et al. (2006) found that respondents 
with higher levels of education tended to perceive lower 
levels of perceived risk. The positive effect of a higher 
education level could be due to more exposure to the 








Table 5. Ethical perception of modern biotechnology across age groups. 
 
Variable Mean score ± Standard deviation Interpretation 
Threatening the natural order of things 
18 - 25 years 3.76  ± 1.03 Moderate 
26 - 40 years 3.72  ± 1.24 Moderate 
≥ 41 years 3.82  ± 1.21 Moderate 
 
Risks to human health 
18 - 25 years 4.59  ± 0.91 Moderate 
26 - 40 years 4.52  ± 1.18 Moderate 
≥ 41 years 4.74  ± 1.38 Moderate 
 
Human rights to modify living things 
18 - 25 years 3.46  ± 1.09 Moderate 
26 - 40 years 3.83  ± 1.18 Moderate 
≥ 41 years 3.21  ± 1.33 Moderate 
 
Monopoly by giant companies and developed countries 
18 - 25 years 5.01  ± 0.94 High 
26 - 40 years 5.07  ± 0.93 High 
≥ 41 years 5.14  ± 1.34 High 
 
The need for proper and appropriate labelling 
18 - 25 years 5.73  ± 1.13 High 
26 - 40 years 5.65  ± 1.10 High 
≥ 41 years 5.73  ± 1.54 High 
 
Perceived benefits 
18 - 25 years 5.31  ± 1.07 High 
26 - 40 years 5.34  ± 1.08 High 
≥ 41 years 5.24  ± 1.57 High 
 
Confidence on government regulation towards GMO 
18 - 25 years 4.18  ± 0.96 Moderate 
26 - 40 years 4.18  ± 1.12 Moderate 
≥ 41 years 3.66  ± 1.34 Moderate 
 




Ethical perception across religion 
 
Respondents from all religions expressed that humans do 
not have the absolute right to modify living things for their 
own benefit (mean score below the mid-point value of 
4.0) (Table 3), whilst they were moderately concerned 
about the possible risks associated with modern biotech-
nology (mean score above the mid-point value of 4.0), 
and stressed the high need for the proper labelling of 
modern biotechnology products (mean score of above 
5.0). The Muslim, Buddhist and Hindu respondents 
perceived modern biotechnology as less threatening to 
the natural order of things (mean score below the mid-
point value of 4.0) compared to the Christian respondents 
who thought otherwise (mean score above the mid-point 
value of 4.0) (Table 7). The Christian respondents were 
also more worried about the possible risks of modern 
biotechnology to human health and had the least confi-
dence in government regulation of GMOs, compared to 
the Muslim, Buddhist and Hindu respondents. ANOVAs 
were significant for the comparison of the factors across 
religions, such as: threatening the natural order of things 
(F = 2.69, p < 0.05); perceived risks (F = 3.42, p < 0.05); 
and confidence (F = 387, p < 0.01). Post hoc tests 
confirmed the significant differences in the opinions of the 
Christians compared to the Hindus  with  regards  to  per- 
 
 




Table 6. Ethical perception of modern biotechnology across educational level. 
 
Variable Mean score ± standard deviation Interpretation 
Threatening the natural order of things 
Secondary 3.77  ± 1.04 Moderate 
Diploma/pre-university 3.74  ± 1.21 Moderate 
University 3.84  ± 0.99 Moderate 
 
Risks to human health 
Secondary 4.56  ± 1.04 Moderate 
Diploma/pre-university 4.65  ± 1.11 Moderate 
University 4.38  ± 1.20 Moderate 
 
Human rights to modify living things 
Secondary 3.41  ± 1.14 Moderate 
Diploma/pre-university 3.58  ± 1.20 Moderate 
University 3.64  ± 1.21 Moderate 
 
Monopoly by giant companies and developed countries 
Secondary 4.95  ± 1.09 Moderate 
Diploma/pre-university 5.17  ± 0.98 High 
University 4.70  ± 0.99 Moderate 
 
The need for proper and appropriate labelling 
Secondary 5.39  ± 1.32 High 
Diploma/pre-university 5.50  ± 1.21 High 
University 5.86  ± 1.12 High 
 
Perceived benefits 
Secondary 5.01  ± 1.31 High 
Diploma/pre-university 4.99  ± 1.10 Moderate 
University 5.50  ± 1.13 High 
 
Confidence on government regulation towards GMO 
Secondary 4.24  ± 1.06 Moderate 
Diploma/pre-university 4.24  ± 1.07 Moderate 
University 4.00  ± 1.12 Moderate 
 




ceived risks and confidence. With regard to monopoly, 
Muslims, Hindus and Christians perceived modern 
biotechnology as being highly monopolised by giant 
companies and developed countries, while the rating of 
the Buddhists was moderate. ANOVA showed significant 
differences in monopoly across religion but post hoc tests 
could not detect specific differences. 
Differences in some dimensions of ethical perception 
across religions are supported by earlier theory and 
studies. According to the cultural approach of risk 
research, the evaluative process of risk perception is 
determined by the norms, value systems and cultural 
idiosyncrasies of societies or societal groups (Rohrmann, 
1994). Macer et al. (2000) also noticed that there was 




Ethical perception across races 
 
All respondents from various major races in Malaysia 
(Malay, Chinese and Indian) agreed that modern 
biotechnology was not very threatening to the natural 
order of things (mean score below the mid-point value of 
4.0) but at the same time they expressed that humans do 
not have the absolute right to modify living things for their 
own benefit (mean score below the mid-point value of 
4.0) (Table 8). They also  expressed  moderate  concerns  
 
 




Table 7. Ethical perception of modern biotechnology across religion. 
 
Variable Mean score ± standard deviation Interpretation 
Threatening the natural order of things 
 Islam 3.66  ± 1.18 Moderate 
 Buddha 3.88  ± 0.90 Moderate 
 Hindu 3.80  ± 1.03 Moderate 
 Christian 4.12  ± 1.24 Moderate 
 
Risks to human health 
 Islam 4.61  ± 1.08 Moderate 
 Buddha 4.70  ± 1.06 Moderate 
 Hindu 4.27  ± 1.13 Moderate 
 Christian 4.92  ± 1.11 Moderate 
 
Human rights to modify living things 
 Islam 3.61  ± 1.13 Moderate 
 Buddha 3.54  ± 1.35 Moderate 
 Hindu 3.62  ± 1.15 Moderate 
 Christian 3.13  ± 1.30 Moderate 
 
Monopoly by giant companies and developed countries 
 Islam 5.02  ± 1.02 High 
 Buddha 4.82  ± 0.89 Moderate 
 Hindu 5.29  ± 1.10 High 
 Christian 5.24  ± 1.02 High 
 
The need for proper and appropriate labelling 
 Islam 5.73  ± 1.18 High 
 Buddha 5.44  ± 1.24 High 
 Hindu 5.61  ± 1.32 High 
 Christian 5.99  ± 0.95 High 
 
Perceived benefits 
 Islam 5.41  ± 1.07 High 
 Buddha 5.01  ± 1.16 High 
 Hindu 5.27  ± 1.29 High 
 Christian 5.22  ± 1.48 High 
 
Confidence on government regulation towards GMO 
 Islam 4.12  ± 1.01 Moderate 
 Buddha 3.92  ± 1.13 Moderate 
 Hindu 4.39  ± 1.25 Moderate 
 Christian 3.74  ± 1.19 Moderate 
 




on the possible risks associated with modern biotech-
nology (mean score above the mid-point value of 4.0), 
were worried about the possibility of the global market of 
modern biotechnology being monopolised by big com-
panies and developed countries (mean score about 5.0 
and above) and stressed the high need for the proper 
labelling of modern biotechnology products (mean score 
above 5.0). With respect to confidence, the respondents 
exhibited only moderate confidence in government 
regulations (mean score about the mid-point value of 
4.0). They also considered modern biotechnology as 
having high benefits to society (mean  score  above  5.0).   
 
 




Table 8. Ethical perception of modern biotechnology across races. 
 
Variable Mean score ± standard deviation Interpretation 
Threatening the natural order of things 
 Malay 3.65  ± 1.19 Moderate 
 Chinese 3.92  ± 1.02 Moderate 
 Indian 3.84  ± 1.03 Moderate 
 
Risks to human health 
 Malay 4.60  ± 1.08 Moderate 
 Chinese 4.63  ± 1.11 Moderate 
 Indian 4.46  ± 1.21 Moderate 
 
Human rights to modify living things 
 Malay 3.60  ± 1.13 Moderate 
 Chinese 3.42  ± 1.28 Moderate 
 Indian 3.49  ± 1.24 Moderate 
 
Monopoly by giant companies and developed countries 
 Malay 5.02  ± 1.02 High 
 Chinese 4.97  ± 1.00 Moderate 
 Indian 5.24  ± 1.08 High 
 
The need for proper and appropriate labelling 
 Malay 5.73  ± 1.19 High 
 Chinese 5.61  ± 1.26 High 
 Indian 5.62  ± 1.26 High 
 
Perceived benefits 
 Malay 5.42  ± 1.07 High 
 Chinese 5.09  ± 1.12 High 
 Indian 5.11  ± 1.52 High 
 
Confidence on government regulation towards GMO 
 Malay 4.12  ± 1.02 Moderate 
 Chinese 3.84  ± 1.17 Moderate 
 Indian 4.17  ± 1.34 Moderate 
 




ANOVA showed significant differences for perceived 
benefits across races (F = 3.61, p < 0.05), but post hoc 
tests could not detect any specific differences. 
Differences in ethical perception towards modern 
biotechnology across races is not surprising as Tucker et 
al. (2006) reported that white respondents tended to 
perceive lower levels of perceived food risks compared to 
non-white respondents.   
 
 
Perception across gender 
 
Gender has been strongly associated with risk judgement 
and attitude (Slovic, 2004). Many studies have found that 
men tend to judge risks as smaller and as less proble-
matic than women (Brody, 1984; De Joy, 1992; Sjoberg 
and Drotz-Sjoberg, 1994). Hossain et al. (2002), and 
Chern and Rikertsen (2002) found no effect of gender on 
the acceptance of GM food while Lin et al. (2004) found a 
low impact of gender on only one biotech product 
(livestock products fed with biotech corn) but no effect of 
gender on the other three GM products surveyed (GM 
soybean oil, input-trait GM rice and neutraceutical GM 
rice). In this study, both male and female respondents 
were in agreement that modern biotechnology was not 
very threatening to the natural order of things (mean 
score below the mid-point value of 4.0) and modern 
biotechnology  was  perceived  as  having  high  potential
 
 




Table 9. Ethical perception of modern biotechnology across gender. 
 
Variable Mean score ± Standard deviation t-test Significant 
Threatening the natural order of things 
Male 3.81  ± 1.20 0.711 0.478 
Female 3.73  ± 1.10   
 
Risks to human health 
Male 4.64  ± 1.23 0.707 0.480 
Female 4.56  ± 1.03   
 
Human rights to modify living things 
Male 3.53  ± 1.29 0.218 0.828 
Female 3.56  ± 1.12   
 
Monopoly by giant companies and developed countries 
Male 5.11  ± 1.13 0.965 0.335 
Female 5.01  ± 0.94   
 
The need for proper and appropriate labelling 
Male 5.63  ± 1.28 0.861 0.390 
Female 5.74  ± 1.15   
 
Perceived benefits 
Male 5.29  ± 1.29 0.222 0.824 
Female 5.32  ± 1.10   
 
Confidence on government regulation towards GMO 
Male 3.89  ± 1.27 2.798 0.003** 
Female 4.21  ± 0.98   
 




benefits to Malaysian society (mean score above 5.0). 
However modern biotechnology was also considered as 
moderately risky to human health (mean score above the 
mid-point score of 4.0), highly monopolised by giant 
companies and developed countries (mean score above 
5.0) which in turn called for the high need of modern 
biotechnology products to be properly and appropriately 
labelled (mean score above 5.0). Meanwhile, female 
respondents had higher confidence in government 
regulation of GMOs (Table 9). The t-test was significant 
for confidence in government regulation of GMOs across 





The Klang Valley public expressed that humans do not 
have the absolute right to modify living things for their 
own benefit (mean score 3.55). Batalion (1999) has 
highlighted that the central problem underlying biotech-
nology is not just its short-term benefits and long-term 
drawbacks, but the overall attempt to “control” living 
nature on an erroneous mechanistic view. Many religions 
do not allow unrestricted interference with life, such as 
genetic engineering (Epstein, 1998). There are principles 
or guidelines on how should we live and what is the right 
in most religions. The majority of the respondents in this 
study were Muslims. In Islam, scientific research is 
encouraged in order to understand natural phenomena 
and the universe, and to observe the signs of Allah’s 
glory and, ultimately, to find the truth (Hajj, 2001). 
However, not everything that is applicable is necessarily 
applicable, it is important to fully consider the purpose of 
any actions and their harmful effects towards humans, 
the environment and society, and the actions must be in 
line with the rules of Shari’ah (Islamic Fiqh Academy, 
2000; Hajj, 2000). 
The respondents in this study also showed moderate 
concerns of the possible risks associated with modern 
biotechnology (mean score 4.59). The Malaysian public is 
not isolated. Their concerns about modern biotechnology 
have   been   echoed   by  people  worldwide.  Europeans  
 
 




(Gaskel et al., 2000, 2003, 2010; Costa-Font and Gil, 
2009), Americans (Priest, 2000), Canadians (Einseidel, 
1997), as well as Asians (Macer et al., 2000), have been 
reported as showing different degrees of concern towards 
various applications of modern biotechnology. 
The Malaysian public centred within the Klang Valley 
region also expressed a high degree of concern about 
the global market of modern biotechnology being 
monopolised by big companies and developed countries 
(with a higher mean score of 5.05). Quaye et al. (2009) 
reported that the public who were concerned about GM 
products in Ghana believed that GM products will only 
benefit big multinational companies, and that this was 
combined with a lack of public trust in their government. 
Uzogara (2000) has highlighted the possibility that 
patenting might allow big corporations to monopolise GM 
plants and animals, beside the fact that patenting is said 
to violate the sanctity of life. Many critics also oppose the 
fact that seeds are now regarded as propriety products, 
moreover with the ‘terminator gene’ technology which 
renders the seeds sterile (Koch, 1998). The farmers are 
forced to buy new seeds each year from multinational 
companies instead of sowing seeds from previous years’ 
harvests. 
The Malaysian public in the Klang Valley region were 
open-minded people. Even though they acknowledged 
that there are risks associated with modern biotech-
nology, they did not perceive modern biotechnology as 
very threatening to the natural order of things (mean 
score 3.76, below the mid-point value of 4.0) and they 
recognised the high benefits that modern biotechnology 
could provide to society (mean score 5.31). Modern 
biotechnology has the potential to be accepted by the 
Malaysians. European public opinion showed that the 
rejection of GM foods was not so much the perception of 
risks but rather the perceived absence of benefit for 
consumers (Gaskell et al., 2004). This was particularly 
true in the “sceptical” group (who perceive GM foods as 
risky and not useful) who made up the majority of the 
Europeans’ sample (60%). As for the “trade-off” group 
(who perceive GM foods as both useful and risky), the 
respondents looked at the perceived benefits first, before 
considering the risks. Looking across the globe, a high 
number of Americans (69%) perceived GM foods as 
useful compared to 46% in Europe, which again relates 
to a higher acceptance of GM foods in the US. 
The respondents in this study exhibited moderate 
confidence in government regulation (mean score 4.09) 
and expressed a high level of need for the proper 
labelling of modern biotechnology products (mean score 
of 5.70). So it is important that the related government 
bodies play their expected role in providing regulation 
and safety protection. The suggestion by Wansink and 
Kim (2001) that, the government be responsible in setting 
the direction and pace of development to prevent ques-





applications/products is highly recommended to the 
Malaysian government regulatory agencies. The public 
expression of the necessity for labelling of modern 
biotechnology applications/products should be heeded by 
the industries. Although, the main function of labels is to 
provide information, labelling may also function as an 
indication of product safety (Wansink and Kim, 2001). 
Although some consumers may use the labelling to avoid 
biotechnology products, others may perceive the explicit 
labelling as a sign of the manufacturers’ confidence in a 
product’s safety. Wansink and Kim (2001) highlighted the 
importance of providing consumers with a sense of 
control over their choices. When their confusion about 
what and how to choose diminishes, consumers will be 
more comfortable and confident in accepting 
biotechnology. 
The empirical results of this study also indicate that 
background variables such as religion, race, age, educa-
tion level and gender have a significant effect on some of 
the dimensions of the Malaysians’ ethical perception 
towards modern biotechnology. These differences should 
be taken into consideration constructively rather than 
negatively. More in-depth empirical studies should be 
carried out to understand the underlying causes behind 
the differences so that appropriate measures can be 
confidently introduced to address the issues on what is 





The Malaysians in the Klang Valley region are open-
minded people. They recognised the potential benefits of 
modern biotechnology and did not see it as totally against 
nature. However, they expressed their concerns that 
humans do not have the absolute right to modify living 
things and called for the need for proper and appropriate 
labelling of modern biotechnology products. They were 
also concerned about the associated risks to human 
health and the possibility of market monopoly by giant 
companies and developed countries. So, it is important 
that the related government bodies play their expected 
role in providing regulation and safety protection to 
increase the public’s confidence in them. More in-depth 
study is needed to evaluate the ethical acceptance of 
specific applications of modern biotechnology, especially 
those involving inter-species gene transfers in Malaysia. 
The empirical results of this study also indicate that 
background variables such as religion, race, age, edu-
cation level and gender have a significant effect on some 
of the dimensions of the Malaysians’ ethical perception of 
modern biotechnology. These differences should be 
taken into consideration constructively rather than nega-
tively. The research findings are useful for understanding 
the social construct of the ethical acceptance of modern 
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